Contact this trialFirst, we need to learn more about you.
Aldose Reductase Inhibitor
Epalrestat for PMM2-CDG
Recruiting1 awardPhase 3
Rochester, Minnesota
This trial is testing a medication called epalrestat, taken by mouth, to see if it helps children with a rare genetic disorder called PMM2-CDG. The goal is to check if the medication is safe and if it improves their metabolism and overall health. Researchers will compare the results to ensure the findings are accurate.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service